“The American Medical Association delayed a measure on Monday that would have allowed physicians to prescribe the drug buprenorphine for the treatment of opioid abuse without obtaining a waiver.
At the AMA’s annual meeting in Chicago, the organization’s House of Delegates voted to refer the proposal for decision at a later time after contentious discussion among the delegates.
Currently, physicians must obtain a waiver before they can prescribe buprenorphine to treat opioid addiction. Doctors must complete an eight-hour training session and other requirements before receiving the waiver.”
Source: ModernHealthcare.com – June 12, 2017